Skip to main content

Health Care

Jump To:

Recent Reports

View More Reports

Open Recommendations

Defense Health Care: DOD Should Improve Monitoring of TRICARE Beneficiaries' Access to Prescription Drugs
GAO-25-107187
Feb 13, 2025
Show
2 Open Recommendations
Agency Affected Recommendation Status
Defense Health Agency The Director of the Defense Health Agency should monitor the contractor's timeliness in dispensing mail order specialty drugs. (Recommendation 1)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Defense Health Agency The Director of the Defense Health Agency should periodically audit TRICARE pharmacy program contractor-reported data for accuracy, as required by DHA's Quality Assurance Surveillance Plan. (Recommendation 2)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.

Hearing Detection and Intervention: Program Connects Deaf or Hard of Hearing Infants and Children to Services, but Actions Needed to Improve Access [Reissued with revisions on Jan. 29, 2025]
GAO-25-106978
Jan 29, 2025
Show
2 Open Recommendations
Agency Affected Recommendation Status
Health Resources and Services Administration The HRSA Administrator should require state EHDI programs to set performance goals that can be used to measure progress in addressing any identified disparities in access for underserved populations and regularly report that progress to HRSA. (Recommendation 1)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Health Resources and Services Administration The HRSA Administrator should assess the results of the state EHDI programs' access disparities performance and use the results to inform future plans for addressing access disparities. (Recommendation 2)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.

Biomedical Research: Strategic Workforce Planning Needed to Address Recruitment and Hiring Challenges at ARPA-H
GAO-25-107418
Dec 26, 2024
Show
3 Open Recommendations
Agency Affected Recommendation Status
Advanced Research Projects Agency for Health The Director of ARPA-H should incorporate leading practices for workforce planning, including developing and implementing a strategic workforce planning process, which could help addresses challenges recruiting and hiring a diverse scientific workforce. (Recommendation 1)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Advanced Research Projects Agency for Health The Director of ARPA-H should take steps to assess data on its scientific personnel to help ensure that recruitment efforts are targeted and effective and track progress towards its goal of maintaining a diverse workforce. (Recommendation 2)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.
Advanced Research Projects Agency for Health The Director of ARPA-H should take steps to assess data on the agency's use of pay flexibilities to hire scientific personnel—including how often incentive payments have been offered and paid. (Recommendation 3)
Open
When we confirm what actions the agency has taken in response to this recommendation, we will provide updated information.

National Institutes of Health: Assessing Efforts to Improve Animal Research Could Lead to Greater Human Health Benefits
GAO-25-107140
Dec 19, 2024
Show
2 Open Recommendations
Agency Affected Recommendation Status
National Institutes of Health The Director of NIH should define short-term goals with measurable targets and time frames related to enhancing reproducibility and translatability in animal research that the agency conducts and supports. For example, some initial goals could include targets for the number of NIH-funded publications that report certain factors that affect reproducibility and translatability, such as randomization and appropriate sample sizes. (Recommendation 1)
Open
The agency agreed with this recommendation. We will update the status of the recommendation when we receive additional information.
National Institutes of Health The Director of NIH should collect evidence needed to assess NIH's efforts to enhance reproducibility and translatability in animal research. This could include steps such as (1) analyzing attempts to reproduce NIH-funded studies or (2) collecting information from projects that attempt to reproduce significant lines of research. (Recommendation 2)
Open
The agency agreed with this recommendation. We will update the status of the recommendation when we receive additional information.
View More Recommendations

Related Pages

GAO Contacts

View More Contacts